Menu Search
Equities

Cerner Corp

CERN*:MEX

Cerner Corp

Actions
  • Price (MXN)1,498.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-3.17%
  • Beta--
Data delayed at least 20 minutes.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and technology enabled services that support the clinical, financial and operational needs of organizations. The Company's segments include Domestic and International. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Australia, Canada, Europe, and the Middle East. Cerner solutions and services help clinicians make care decisions and assist organizations in managing the health of their populations. It also offers an integrated clinical and financial systems to help manage day-to-day revenue functions to support clinical, financial and operational needs. Cerner's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform.

  • Revenue in USD (TTM)5.51bn
  • Net income in USD780.09m
  • Incorporated1986
  • Employees26.40k
  • Location
    Cerner Corp2800 ROCKCREEK PKWYW0162, ATTN: CERNER LEGALKANSAS CITY 64117United StatesUSA
  • Phone+1 (816) 221-1024
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cerner.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		CERN:NSQ since
announced		Transaction
value
Kantar Health LLCAnnounced16 Dec 202016 Dec 2020Announced-0.90%375.00m
Data delayed at least 15 minutes, as of Apr 19 2021 21:00 BST.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.